ask="4.200"
ask_size="400"
average_daily_volume="41114"
bid="1.000"
bid_size="100"
book_value="1.471"
change="-0.125"
change_from_200_day_moving_average="-2.522"
change_from_50_day_moving_average="-0.945"
change_from_52_week_high="-8.515"
change_From_52_week_low="0.075"
change_in_percent="-2.907%"
close="4.175"
dividend_pay_date="N/A"
dividend_per_share="N/A"
dividend_yield="N/A"
earnings_per_share="-1.293"
ebitda="-23.06M"
eps_estimate_current_year="-1.460"
eps_estimate_next_quarter="-0.450"
eps_estimate_next_year="-1.530"
ex_dividend_date="N/A"
float_shares="11135000"
high="4.400"
high_52_weeks="12.690"
last_trade_date="2/17/2017"
last_trade_price="4.175"
last_trade_size="6679"
last_trade_time="4:00pm"
low="4.100"
low_52_weeks="4.100"
market_capitalization="79.96M"
moving_average_200_day="6.697"
moving_average_50_day="5.120"
name="Axsome Therapeutics
Inc."
notes="N/A"
one_year_target_price="20.330"
open="4.400"
pe_ratio="N/A"
peg_ratio="0.000"
percent_change_from_200_day_moving_average="-37.660%"
percent_change_from_50_day_moving_average="-18.455%"
percent_change_from_52_week_high="-67.100%"
percent_change_from_52_week_low="+1.829%"
previous_close="4.300"
price_eps_estimate_current_year="N/A"
price_eps_Estimate_next_year="N/A"
price_per_book="2.923"
price_per_sales="N/A"
revenue="N/A"
shares_outstanding="19153000"
short_ratio="6.370"
stock_exchange="NCM"
symbol="AXSM"
volume="63293"
weeks_range_52="4.100 - 12.690"
